Plasma and metabolic abnormalities in Gaucher's disease. (Q41719188)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497858%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Plasma and metabolic abnormalities in Gaucher's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497858%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497858%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C E Hollak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497858%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

1 reference

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497858%20AND%20SRC:MED&resulttype=core&format=json

Best Practice and Research: Clinical Haematology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497858%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497858%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497858%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

691-709

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497858%20AND%20SRC:MED&resulttype=core&format=json

Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Abnormal neutrophil chemotaxis in Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Resting energy expenditure in Gaucher's disease type 1: effect of Gaucher's cell burden on energy requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Interaction between a serum factor and T lymphocytes in Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

High incidence of factor XI deficiency in Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Coagulation abnormalities in patients with Gaucher's disease: effect of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Determination of serum acid phosphatase in gaucher's disease using 4-methylumbelliferyl phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Elevation of serum beta-hexosaminidase and alpha-D-mannosidase in type 2 Gaucher disease: a clinical and biochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Indomethacin stimulates basal glucose production in humans without changes in concentrations of glucoregulatory hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Pentoxifylline inhibits basal glucose production in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Increased basal glucose production in type 1 Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Biologically active products of stimulated liver macrophages (Kupffer cells).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Enzyme replacement therapy of infantile Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Enzyme infusion therapy of the Norrbottnian (type 3) Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and B-cell proliferations?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Peripheral retinal vascular lesions in a patient with Gaucher disease and factor XI deficiency. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Coexistence of Gaucher's Disease and Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Increased circulating levels of transcobalamin ii in gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Elevated plasma chitotriosidase activity in various lysosomal storage disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Primary amyloidosis associated with Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Regression of bone lesions in Gaucher's disease during treatment with aminohydroxypropylidene bisphosphonate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Individualised low-dose alglucerase therapy for type 1 Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

A case of type I Gaucher disease with cardiopulmonary amyloidosis and chitotriosidase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Acid hydrolases in serum from patients with lysosomal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Interferon-gamma and interleukin-4 down-regulate soluble CD14 release in human monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Increased Circulating Soluble Cd14 Is Associated With High Mortality In Gram-Negative Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Abnormalities in lipoprotein metabolism in Gaucher type 1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Elevation of Serum Angiotensin-Converting Enzyme in Gaucher's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Type 5 acid phosphatase. Sequence, expression and chromosomal localization of a differentiation-associated protein of the human macrophage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Age dependency of serum acid phosphatase in controls and Gaucher patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Characterization of lysosomal hydrolases that are elevated in Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Marked variation in blood beta-hexosaminidase in Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Interleukin-6, a new target for therapy in multiple myeloma?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Biliary excretion of glycolipid in induced or inherited glucosylceramide lipidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Tartrate-resistant, purple acid phosphatase in Gaucher cells of the spleen. Immuno- and cytochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Endotoxin-neutralizing capacity of soluble CD14

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Elevated serum and spleen angiotensin converting enzyme and serum lysozyme in Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Immunofluorescent detection of angiotensin-converting enzyme (ACE) in Gaucher cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

HPLC analysis of neutral glycolipids: an aid in the diagnosis of lysosomal storage disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Plasma methylumbelliferyl-tetra-N-acetyl-beta-d-chitotetraoside hydrolase as a parameter during treatment of gaucher patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Non-identity of human plasma lysozyme and 4-methylumbelliferyl-tetra-N-acetyl-beta-D-chitotetraoside hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

Studies on the nature of the increased serum acid phosphatase in Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980034-0

7 January 2021

10.1016/S0950-3536(97)80034-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497858%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497858%20AND%20SRC:MED&resulttype=core&format=json